Journal of Renal Nutrition
Volume 20, Issue 5 , Pages 281-292.e7 , September 2010

Relationship Between Body Mass Index and Mortality in Adults on Maintenance Hemodialysis: A Systematic Review

  • Marietjie Herselman, PhD

      Affiliations

    • Division of Human Nutrition, Stellenbosch University, Tygerberg, South Africa
    • Tygerberg Academic Hospital, Tygerberg, South Africa
    • Corresponding Author InformationAddress reprints requests to Marietjie Herselman, PhD, Division of Human Nutrition, Faculty of Health Sciences, Stellenbosch University, PO Box 19063, Tygerberg 7505, South Africa.
    • ,
  • Nazeema Esau, BSc Diet

      Affiliations

    • Division of Human Nutrition, Stellenbosch University, Tygerberg, South Africa
    • Tygerberg Academic Hospital, Tygerberg, South Africa
    • ,
  • Jean-Marie Kruger, MNutr

      Affiliations

    • Division of Human Nutrition, Stellenbosch University, Tygerberg, South Africa
    • Tygerberg Academic Hospital, Tygerberg, South Africa
    • ,
  • Demetre Labadarios, PhD

      Affiliations

    • Tygerberg Academic Hospital, Tygerberg, South Africa
    • Knowledge Systems, Human Sciences Research Council, Cape Town, South Africa
    • ,
  • Mohammed Rafique Moosa, MD

      Affiliations

    • Tygerberg Academic Hospital, Tygerberg, South Africa
    • Department of Medicine, Stellenbosch University, Tygerberg, South Africa

References 

  1. WHO: Prevention and Control of Noncommunicable Diseases: Implementation of the Global Strategy. Geneva, Switzerland: Report by the Secretariat, World Health Organization; 2008;
  2. Abrass CK. Overview: obesity: what does it have to do with kidney disease?. J Am Soc Nephrol. 2004;15:2768–2772
  3. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol. 2008;294:F685–F696
  4. McGill JB, Furth S, Frederick J, et al. Obesity: growing impact on CKD. ACKD. 2006;13:323–324
  5. Wang Y, Chen X, Song Y, et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73:19
  6. Stengel B, Tarver-Carr ME, Powe N, et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemioloy. 2003;14:479–487
  7. Tozawa M, Iseki K, Iseki C, et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002;62:1743–1749
  8. Abbott KC, Glanton CW, Trespalacios FC, et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int. 2004;65:597–605
  9. Xue JL, Dahl D, Ebben JP, et al. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42:1013–1019
  10. Dwyer JT, Larive B, Leung J, et al. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?. Kidney Int. 2005;68:1766–1776
  11. Satomura A, Endo M, Fujita T, et al. Serum mannose-binding lectin levels in maintenance hemodialysis patients: impact on all-cause mortality. Nephron Clin Pract. 2006;102:c93–c99
  12. WHO: Avoiding Heart Attacks and Strokes. Geneva, Switzerland: World Health Organization; 2005;
  13. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Available at: http://www.kidney.org/professionals/kdoqi/guidelines_lipids/index.htm2003;Accessed March 17, 2009
  14. Kasiske B, Cosio FG, Beto J, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant. 2004;4(Suppl 7):S13–S53
  15. Herselman M, Esau N, Kruger JM, et al. Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. Nutrition. 2010;26:10–32
  16. Gøtzsche PC, Harden A. Searching for non-randomised studies. NRSMG, 7th draft. Available at: www.cochrane.dk/nrsmg/docs/chap3.rtf2000;Accessed October 12, 2005
  17. Cochrane Renal Group: Renal Group Data Extraction Form 2005. Available at: http://www.cochrane-renal.org/docs/data_extraction_form.doc. Accessed November 27, 2008
  18. Khan KS, Ter Riet G, Glanville J, et al. Undertaking Systematic Reviews of research on Effectiveness. CRD's Guidance for those Carrying out or Commissioning Reviews. CRD Report Number 4. 2nd edn. York, University of York: York Publishing Services Ltd; 2001;
  19. STROBE Statement of essential items Version 3. Available at: http://www.strobe-statement.org/PDF%20hochladen/STROBE-Checklist-Version3.pdf. Accessed November 8, 2005
  20. Alderson P and Green S (eds): Cochrane Collaboration open learning material for reviewers, Version 1.1. 2002. Available at: http://www.cochrane-net.org/openlearning/. Accessed February 22, 2007
  21. Wells G, Shea B, O' Connell D, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Available at: http://www.iri.ca/programs/ccu/oxford.htm. Accessed October 13, 2005
  22. Khan KS, Kunz R, Kleijnen J, et al. Systematic Reviews to Support Evidence-Based Medicine. London, UK: The Royal Society of Medicine Press Ltd; 2003;
  23. The COCHRANE COLLABORATION: Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. Available at: http://www.cochrane-handbook.org/. Accessed October 13, 2005
  24. Hintze J. NCSS Statistical and Power Analysis Software Package. Kaysville, UT: Number Cruncher Statitical Systems; 2007;
  25. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis. 1998;32:107–114
  26. De Mutsert R, Snijder MB, Van der Sman-de Beer F, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18:967–974
  27. Hanson JA, Hulbert-Shearon TE, Ojo AO, et al. Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol. 1999;19:625–633
  28. Leavey SF, McCullough K, Hecking E, et al. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386–2394
  29. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658
  30. Fleischmann E, Teal N, Dudley J, et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55:1560–1567
  31. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003;14:1012–1021
  32. Termorshuizen F, Dekker FW, van Manen JG, et al. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15:1061–1070
  33. Chen KH, Lin-Tan DT, Huang WH, et al. Cardiothoracic ratio, malnutrition, inflammation, and two-year mortality in non-diabetic patients on maintenance hemodialysis. Kidney Blood Press Res. 2008;31:143–151
  34. Costa-Hong V, Jorgetti V, Gowdak LHW, et al. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery. 2007;142:699–703
  35. Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care. 2001;24:909–913
  36. Nascimento MM, Pecoits-Filho R, Qureshi AR, et al. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant. 2004;19:2803–2809
  37. Saudan P, Kossovsky M, Halabi G, et al. Quality of care and survival of haemodialysed patients in western Switzerland. Nephrol Dial Transplant. 2008;23:1975–1981
  38. Terrier N, Jaussent I, Dupuy AM, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant. 2008;23:345–353
  39. Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251–1263
  40. Kimmel PL, Chawla LS, Amarasinghe A, et al. Anthropometric measures, cytokines and survival in haemodialysis patients. Nephrol Dial Transplant. 2003;18:326–332
  41. Mallamaci F, Zoccali C, Tripepi G, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002;61:609–614
  42. Nishizawa Y, Shoji T, Maekawa K, et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2003;41(suppl 1):S76–S79
  43. Frankenfield DL, Rocco MV, Roman SH, et al. Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J Am Soc Nephrol. 2003;14:180–186
  44. Kaizu Y, Tsunega Y, Yoneyama T, et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol. 1998;50:44–50
  45. Leavey SF, Strawderman RL, Jones CA, et al. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31:997–1006
  46. Lorenzo V, Martin M, Rufino M, et al. High prevalence of overweight in a stable Spanish hemodialysis population: a cross sectional study. J Ren Nutr. 2003;13:52–59
  47. Port FK, Ashby VB, Dhingra RK, et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13:1061–1066
  48. Beddhu S, Pappas LM, Ramkumar N, et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol. 2003;14:2366–2372
  49. Reddan DN, Klassen PS, Szczech LA, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18:1167–1173
  50. Tepel M, Giet MV, Park A, et al. Association of calcium channel blockers and mortality in haemodialysis patients. Clin Sci (Lond). 2002;103:511–515
  51. Nishizawa Y, Shoji T, Kakiya R, et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int. 2003;84(suppl):S117–S120
  52. Beddhu S, Cheung AK, Larive B, et al. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007;17:372–380
  53. In:  Lee RD,  Nieman DC editor. 3rd edn. Nutritional Assessment. Chap 6:London: McGraw Hill; 2003;
  54. Inoue S, Zimmet P, Caterson I, et al. The Asia-Pacific perspective: redefining obesity and its treatment. Geveva, Switzerland: World Health Organisation; 2000;22
  55. James PT, Leach R, Kalamara E, et al. The worldwide obesity epidemic. Obesity Res. 2001;9(suppl 4):2287–233
  56. Globalization, Diets and Noncommunicable Diseases. Geneva, Switzerland: World Health Organization; 2002;
  57. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530–1538
  58. Sturm R, Wells KB. Does obesity contribute as much to morbidity as poverty or smoking?. Public Health. 2001;115:229–235
  59. MacMahon SW, Wilcken DE, Macdonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med. 1986;314:334–339
  60. Lavie CJ, Milani RV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol. 1997;79:397–401
  61. Szczech LA, Reddan DN, Klassen PS, et al. Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients. Nephrol Dial Transplant. 2003;18:1585–1591
  62. Wigfield CH, Lindsey JD, Muñoz A, et al. Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI ≥40. Eur J Cardiothorac Surg. 2006;29:434–440
  63. Pischon T, Sharma AM. Obesity as a risk factor in renal transplant patients. Nephrol Dial Transplant. 2001;16:14–17
  64. Johnson DW, Isbel NM, Brown AM, et al. The effect of obesity on renal transplant outcomes. Transplantation. 2002;74:675–681
  65. Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  66. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J. 2001;22:1318–1327
  67. Hall JA, French TK, Rasmusson KD, et al. The paradox of obesity in patients with heart failure. J Am Acad Nurse Pract. 2005;17:542–546
  68. Horwich TB, Fonarow GC. The impact of obesity on survival in patients with heart failure. Heart Fail Monit. 2002;3:8–14
  69. Lavie CJ, Milani RV. Obesity and cardiovascular disease: the Hippocrates paradox?. J Am Coll Cardiol. 2003;42:677–679
  70. Lavie CJ, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891–894
  71. Lissin LW, Gauri AJ, Froelicher VF, et al. The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Card Fail. 2002;8:206–215
  72. Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J. 2001;22:1318–1327
  73. Strandberg TE, Strandberg AY, Salomaa VV, et al. Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men. Eur Heart J. 2009;30:1720–1727
  74. Chazot C, Gassia J-P, Di Benedetto A, et al. Is there any survival advantage of obesity in Southern European haemodialysis patients?. Nephrol Dial Transplant. 2009;24:2871–2876
  75. Takata Y, Ansai T, Soh I, et al. Association between body mass index and mortality in an 80-year old population. J Am Geriatr Soc. 2007;55:913–917
  76. Diehr P, O'Meara ES, Fitzpatrick A, et al. Weight, mortality, years of healthy life, and active life expectancy in older adults. J Am Geriatr Soc. 2008;56:76–83
  77. McAuley P, Myers J, Abella J, et al. Body mass, fitness and survival in veteran patients: another obesity paradox?. Am J Med. 2007;120:518–524
  78. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433–442
  79. Corrada M, Kawas CH, Mozaffar F, et al. Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol. 2006;163:938–949
  80. Marton KI, Sox HC, Krupp JR. Involuntary weight loss: diagnostic and prognostic significance. Ann Intern Med. 1981;95:568–574
  81. Rabinovitz M, Pitlik SD, Leifer M, et al. Unintentional weight loss. A retrospective analysis of 154 cases. Arch Intern Med. 1986;146:186–187
  82. Bilbao-Garay J, Barba R, Losa-Garcia JE, et al. Assessing clinical probability of organic disease in patients with involuntary weight loss: a simple score. Eur J Intern Med. 2002;13:240–245
  83. Locher L, Roth DL, Ritchie CS, et al. Body mass index, weight loss, and mortality in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2007;62:1389–1392
  84. Wannamethee SG, Shaper AG, Lennon L. Reasons for intentional weight loss, unintentional weight loss, and mortality in older men. Arch Intern Med. 2005;165:1035–1040
  85. Williamson DF, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol. 1995;141:1128–1141
  86. Yaari S, Goldbourt U. Voluntary and involuntary weight loss: associations with long term mortality in 9228 middle-aged men and elderly men. Am J Epidemiol. 1998;148:546–555
  87. Williamson DF, Pamuk E, Thun M, et al. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol. 1999;149:491–503
  88. French SA, Folsom AR, Jeffery RW, et al. Prospective study of intentional weight loss and mortality in older women: the Iowa Women's Health Study. Am J Epidemiol. 1999;149:504–514
  89. Gregg EW, Gerzoff RB, Thompson TJ, et al. Intentional weight loss and death in overweight and obese US adults 35 years of age and older. Ann Intern Med. 2003;138:383–389
  90. Williamson DF, Flanders D, Thompson TJ, et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000;23:1499–1504
  91. Wannamethee SG, Shaper AG, Walker M. Overweight and obesity and weight change in middle-aged men: impact on cardiovascular disease and diabetes. J Epidemiol Comm Health (in press)
  92. Field AE, Malspeis S, Willett WC. Weight cycling and mortality among middle-aged or older women. Arch Intern Med. 2009;169:881–886
  93. Wallace JI, Schwartz RS, LaCroix AZ, et al. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc. 1995;43:329–337
  94. Schooling CM, Lam TH, Li ZB, et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med. 2006;166:1498–1504
  95. Morley JE, Thomas DR, Wilson MG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735–743
  96. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif. 2001;19:53–61
  97. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543–554
  98. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001;12:1549–1557
  99. Mattern WD, Hak LJ, Lamanna RW, et al. Malnutrition, altered immune function, and the risk of infection in maintenance hemodialysis patients. Am J Kidney Dis. 1982;1:206–218
  100. Walrand S, Moreau K, Caldefie F, et al. Specific and nonspecific immune responses to fasting and refeeding differ in healthy young adult and elderly persons. Am J Clin Nutr. 2001;74:670–678
  101. Huang CC, Cheng KF, Wu HDI. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int. 2008;28(suppl 3):S15–S20
  102. Van Dijk PCW, Jager KJ, de Charro F, et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001;16:1120–1129
  103. Banerjee D, Ma JZ, Collins AJ, et al. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2:1186–1190
  104. Nigam A, Wright RS, Allison TG, et al. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol. 2006;110:153–159
  105. Epstein BJ, Gums JG. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations. Ann Pharmacother. 2005;39:470–480
  106. Galandi D, Schwarzer G, Antes G. The demise of the randomised controlled trial: bibliometric study of the German-language health care literature, 1948 to 2004. BMC Med Res Methodol. 2000;6:30
  107. In:  Higgins JPT,  Green S editor. Cochrane Handbook for Systematic Reviews of Interventions. West Sussex, UK: John Wiley & Sons Ltd; 2008;

PII: S1051-2276(10)00081-6

doi: 10.1053/j.jrn.2010.03.010

Journal of Renal Nutrition
Volume 20, Issue 5 , Pages 281-292.e7 , September 2010

Article Tools

* Image Usage & Resolution